Editorial 遺伝子組換えサケの20年 2015年12月1日 Nature Biotechnology 33, 12 doi: 10.1038/nbt.3438 Here's hoping that a proposed shakeup of US regulations will mean that new biotech products avoid AquaAdvantage salmon's two-decade upstream struggle to regulatory approval. Full text PDF 目次へ戻る
